Lymphocyte Dynamics in Radiation Oncology

Radiation therapy exerts its antitumour effects predominantly through DNA damage in cancer cells, yet circulating and tissue-resident lymphocytes also absorb substantial ionising radiation. Lymphocyte subpopulations, including T cells, B cells and natural killer cells, exhibit high radiosensitivity, leading to profound and often prolonged lymphopenia. This depletion can impair systemic and intratumoural immunity, reduce tumour surveillance and compromise combination strategies with immunotherapy. Recovery dynamics vary across lymphocyte lineages; some subsets repopulate within weeks while others remain suppressed for months. Radiation dose, fractionation schedule, irradiated volume and anatomical site all modulate lymphocyte kinetics and influence the balance between tumour control and immune preservation. Recent advances in computational modelling have begun to quantify these interactions, offering a framework to predict lymphopenia onset and recovery trajectories. Strategies that spare critical blood‐forming organs, optimise beam delivery or adopt hypofractionated regimens can mitigate lymphopenia and support antitumour immunity. Integrating lymphocyte dynamics into treatment planning promises to refine personalised radiotherapy, enhance immunotherapy synergy and improve clinical outcomes across diverse tumour types.

Research from Nature Portfolio

A detailed comparative study examined radiosensitivity across human blood cell populations under uniform conditions. Peripheral T and B lymphocytes were found to be highly susceptible to apoptosis at low radiation doses, with a dose‐response continuum rather than a clear threshold. In contrast, monocytes, macrophages and dendritic cells demonstrated greater radio‐resistance. DNA double‐strand‐break repair capacity, assessed by γH2AX foci resolution, was retained in lymphoid and progenitor cells despite their sensitivity. In patients undergoing total‐body irradiation, circulating T cells sharply declined after the first fraction and remained depleted, whereas monocyte counts were relatively stable. This work elucidates the divergent responses of lymphoid versus myeloid lineages to ionising radiation and underscores the importance of cell‐type–specific sensitivity in designing lymphocyte‐sparing protocols.

Lymphocyte Dynamics in Radiation Oncology publication trend

The graph below shows the total number of articles in lymphocyte dynamics in radiation oncology across all publications each year (not limited to Nature Index journals).

Technical terms

Lymphopenia: A reduction in the number of circulating lymphocytes below normal ranges following treatment or disease.

Tumour microenvironment: The cellular and molecular milieu surrounding a tumour, including immune cells, stromal elements and signalling molecules.

Ionising radiation: High‐energy radiation capable of removing electrons from atoms, used to damage cancer cell DNA.

Fractionation: The division of a total radiation dose into multiple smaller doses delivered over time to maximise tumour kill while sparing normal tissue.

Radiosensitivity: The relative susceptibility of cells or tissues to damage by ionising radiation.

References

1. Beyond lymphopenia, unraveling radiation-induced leucocyte subpopulation kinetics and mechanisms through modeling approaches. Journal of Experimental & Clinical Cancer Research (2023).
2. Immune microenvironment remodeling after radiation of a progressing brain metastasis. Cell Reports Medicine (2023).
3. The current understanding of the immune landscape relative to radiotherapy across tumor types. Frontiers in Immunology (2023).
4. A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma. Journal for ImmunoTherapy of Cancer (2016).
5. Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma. Radiation Oncology (2017).
6. Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation. International Journal of Particle Therapy (2017).
7. Comparison of DNA repair and radiosensitivity of different blood cell populations. Scientific Reports (2021).